RATIONALE: Allopregnanolone (ALLO) is an endogenous neuroactive steroid thought to alter the reinforcement value of alcohol (ethanol) due to its actions as a positive modulator of the GABAA receptor (GABAAR). Extrasynaptic GABAARs may be a particularly sensitive target of ethanol and neuroactive steroids. Previous work showed that systemic injections of an ALLO analog, ganaxolone (GAN), or an extrasynaptic GABAAR agonist (gaboxadol; THIP) decreased ethanol intake in male mice with limited access to ethanol. OBJECTIVES: The present studies tested whether activation of GABAARs in the nucleus accumbens (NAc) shell by GAN or THIP was sufficient to reduce ethanol intake. C57BL/6J male mice had 2-h access to 10 % ethanol (10E) and water, and 10E intake was measured following site-specific infusions of GAN or THIP. RESULTS: Decreases in limited-access 10E consumption were observed following site-specific bilateral infusions of either drug into the NAc shell. Significant changes in intake were absent when the drugs were infused in a region dorsal to the target site (GAN) or into the lateral ventricle (THIP). Locomotor data confirmed that the decreases in intake were not due to a sedative effect of the drugs. CONCLUSIONS: These data demonstrate the sufficiency of GABAAR activation by a positive allosteric modulator or an agonist with selectivity for extrasynaptic GABAARs to decrease ethanol consumption in mice. Importantly, more refined GABAAR-active targets that decrease ethanol intake may enhance our understanding and ability to treat alcohol use disorders.
RATIONALE: Allopregnanolone (ALLO) is an endogenous neuroactive steroid thought to alter the reinforcement value of alcohol (ethanol) due to its actions as a positive modulator of the GABAA receptor (GABAAR). Extrasynaptic GABAARs may be a particularly sensitive target of ethanol and neuroactive steroids. Previous work showed that systemic injections of an ALLO analog, ganaxolone (GAN), or an extrasynaptic GABAAR agonist (gaboxadol; THIP) decreased ethanol intake in male mice with limited access to ethanol. OBJECTIVES: The present studies tested whether activation of GABAARs in the nucleus accumbens (NAc) shell by GAN or THIP was sufficient to reduce ethanol intake. C57BL/6J male mice had 2-h access to 10 % ethanol (10E) and water, and 10E intake was measured following site-specific infusions of GAN or THIP. RESULTS: Decreases in limited-access 10E consumption were observed following site-specific bilateral infusions of either drug into the NAc shell. Significant changes in intake were absent when the drugs were infused in a region dorsal to the target site (GAN) or into the lateral ventricle (THIP). Locomotor data confirmed that the decreases in intake were not due to a sedative effect of the drugs. CONCLUSIONS: These data demonstrate the sufficiency of GABAAR activation by a positive allosteric modulator or an agonist with selectivity for extrasynaptic GABAARs to decrease ethanol consumption in mice. Importantly, more refined GABAAR-active targets that decrease ethanol intake may enhance our understanding and ability to treat alcohol use disorders.
Authors: R M Mihalek; B J Bowers; J M Wehner; J E Kralic; M J VanDoren; A L Morrow; G E Homanics Journal: Alcohol Clin Exp Res Date: 2001-12 Impact factor: 3.455
Authors: R M Mihalek; P K Banerjee; E R Korpi; J J Quinlan; L L Firestone; Z P Mi; C Lagenaur; V Tretter; W Sieghart; S G Anagnostaras; J R Sage; M S Fanselow; A Guidotti; I Spigelman; Z Li; T M DeLorey; R W Olsen; G E Homanics Journal: Proc Natl Acad Sci U S A Date: 1999-10-26 Impact factor: 11.205
Authors: Josh Steven Kaplan; Michelle A Nipper; Ben D Richardson; Jeremiah Jensen; Melinda Helms; Deborah Ann Finn; David James Rossi Journal: J Neurosci Date: 2016-08-31 Impact factor: 6.167
Authors: Emily L Newman; Georgia Gunner; Polly Huynh; Darrel Gachette; Stephen J Moss; Trevor G Smart; Uwe Rudolph; Joseph F DeBold; Klaus A Miczek Journal: Alcohol Clin Exp Res Date: 2016-09-26 Impact factor: 3.455
Authors: Verginia C Cuzon Carlson; Carlos F Aylwin; Timothy L Carlson; Matthew Ford; Houda Mesnaoui; Alejandro Lomniczi; Betsy Ferguson; Rita P Cervera-Juanes Journal: Addict Biol Date: 2021-10-26 Impact factor: 4.280